Results

Total Results: 1,851 records

Showing results for "adverse".

121. Urinary-Incontinence-Treatment Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/urinary-incontinence-treatment_surveillance.pdf
     October 29, 2012 - events: 1 serious adverse events: The [(n/N (%)] was 6/127 (5) versus 4/120 (3); p= 0.70 Any adverse … events [(n/N (%)] 1 serious adverse events: 6/127 (5) vs. 4/120 (3); p= 0.70 Any adverse events: … Fesoterodine resulted in higher rates of adverse effects and discontinuation of treatment due to adverse … events [(n/N (%)] 1 serious adverse events: 6/127 (5) vs. 4/120 (3); p= 0.70 Any adverse events … Fesoterodine resulted in higher rates of adverse effects and discontinuation of treatment due to adverse

122. Template for Reports Developed (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/allergy-seasonal_research-protocol.pdf
     March 08, 2012 - Adverse local effects may include nosebleeds, stinging, burning, and dryness. … Other local adverse effects may include nosebleeds, stinging, burning, and dryness. … Local adverse effects may include nosebleeds and nasal and oral dryness. … How do adverse effects vary with intermittent or continuous use? … Table 4 lists systemic and local adverse effects of interest.

123. Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/thromboembolism-update-executive-170622.pdf
     June 01, 2017 - for adverse events (not for VTE outcomes). … for adverse events (not for VTE outcomes). … Data were insufficient for adverse events. 18 Table D. … for adverse events (not for VTE outcomes). … for adverse events (not for VTE outcomes).

124. Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/thromboembolism-update-executive-170622.pdf
     June 01, 2017 - for adverse events (not for VTE outcomes). … for adverse events (not for VTE outcomes). … Data were insufficient for adverse events. 18 Table D. … for adverse events (not for VTE outcomes). … for adverse events (not for VTE outcomes).

125. Insomnia Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/insomnia_executive.pdf
     December 01, 2015 - Evidence on adverse effects was insufficient. … Adverse effects did not differ between groups. … Data were insufficient for adverse effects. … Withdrawals due to adverse effects, but not any specific adverse effect or overall withdrawals, were … long-term use or rare adverse effects.

126. Treatments for Seasonal Allergic Rhinitis | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/allergy-seasonal/research-protocol
     March 08, 2012 - Adverse effects of intranasal antihistamines may include a bitter aftertaste. … Adverse local effects may include nosebleeds, stinging, burning, and dryness. … Local adverse effects may include nosebleeds and nasal and oral dryness. … How do adverse effects vary with intermittent or continuous use? … Table 4 lists systemic and local adverse effects of interest.

127. Migraine-Adults-Executive-130408 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-adults-executive-130408.pdf
     April 01, 2013 - To assess adverse effects and treatment discontinuation due to adverse effects, we analyzed all included … Adverse Effects With Drugs for Chronic Migraine Onabotulinumtoxin A resulted in adverse effects and … Increase in risk of adverse effects was dose responsive. … Adverse Effects With Drugs for Episodic Migraine Bothersome adverse effects leading to treatment discontinuation … in trials with higher placebo rates of adverse effects.

128. Recurrent Nephrolithiasis in Adults: A Comparative Effectiveness Review of Preventive Medical Strategies | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/kidney-stone-prevention/research-protocol
     June 15, 2011 - Does the risk of adverse effects differ according to patient baseline diet and fluid intake? … Does the risk of adverse effects differ according to characteristics of stone history? … Does the risk of adverse effects differ according to patient baseline diet and fluid intake? … Does the risk of adverse effects differ according to characteristics of stone history? … The rationale for the shorter required duration for studies reporting adverse effects is that many adverse

129. Epilepsy-Medicine Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/epilepsy-medicine_surveillance.pdf
     August 01, 2012 - informative - There is new evidence available for KQ1 (effectiveness, health outcomes) and KQ3 (adverse … , bone density, and cosmetic adverse effects? … Gastrointestinal adverse effects of antiepileptic drugs in intractable epileptic patients. … , bone density, and cosmetic adverse effects? … , bone density, and cosmetic adverse effects?

130. Epilepsy-Medicine Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_surveillance.pdf
     August 01, 2012 - informative - There is new evidence available for KQ1 (effectiveness, health outcomes) and KQ3 (adverse … , bone density, and cosmetic adverse effects? … Gastrointestinal adverse effects of antiepileptic drugs in intractable epileptic patients. … , bone density, and cosmetic adverse effects? … , bone density, and cosmetic adverse effects?

131. Pharmacokinetic/Pharmacodynamic Measures for Guiding Antibiotic Treatment for Hospital-Acquired Pneumonia | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/pneumonia-antibiotic-treatment/research
     November 24, 2014 - to clinical response, mechanical ventilation, morbidity, mortality, or rates of antibiotic-related adverse … Clinical response, duration of mechanical ventilation, superinfection, rates of antibiotic-related adverse … events, and infusion-related adverse effects did not differ significantly in any study.

132. Update Topic Brief CER 27 NSD FINAL_SJ final (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_overview.pdf
     January 17, 2014 - mellitus, what is the comparative safety of the following treatment options in terms of the following adverse … addition to updating information on the potential benefits of available treatments, conclusions regarding adverse … There have been a number of potential adverse events associated with rosiglitazone (e.g. increased

133. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain_executive.pdf
     October 01, 2011 - due to any adverse event did not reach statistical significance). … , any GI adverse events (RR 0.31, 95% CI 0.24 to 0.39), and withdrawals due to GI adverse events (RR … , 95% CI 0.70 to 0.99), but there was no difference in risk of GI adverse events, withdrawal due to adverse … events, or withdrawal due to GI adverse events. … events and higher risk of dermatologic adverse compared to oral NSAIDs.

134. Comparative Effectiveness of Angiotensin Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), and Direct Renin Inhibitors for Treating Essential Hypertension – An Update of the 2007 Report | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/ace-inhibitor-arb-update/research-protocol
     May 07, 2010 - event rates, overall adverse event rates, and withdrawals due to adverse events, withdrawal rates, switch … rates) Specific adverse events (including, but not limited to, weight gain, impaired renal function … Also, adverse events (including, but not limited to, weight gain, impaired renal function, angioedema … events, withdrawals due to adverse events, serious adverse events reported, withdrawal rates, switch … rates) Specific adverse events , including but not limited to weight gain, impaired renal function

135. Efficacy and Comparative Effectiveness of Off-Label Use of Atypical Antipsychotics – Update | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/atypical-antipsychotics-off-label-update/research-protocol
     May 19, 2010 - It also found strong evidence that atypical antipsychotics can increase chances of adverse events such … between the increased risk of death and antipsychotics drugs, and comparison of the development of adverse … Outcome measures for harms, or adverse events, are the same as in KQ4 below. … Adverse events will be analyzed for all controlled trials as well as observational studies with at least … “Adverse Events” section: adverse events will be analyzed for all controlled trials as well as observational

136. Psoriatic Arthritis Surveillance Assesment_CER 54_Low (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_surveillance.pdf
     March 01, 2013 - Overall adverse event profiles appeared to be similar for biologic DMARDs and placebo. … for at least 28 weeks. 78.2% had at least one adverse event (AE), but only 4.6% had a No safety … Common adverse events include: nausea/ vomiting, respiratory infection, abdominal pain, abnormal … ACR50 response rates were Did not conduct statistical tests on adverse events data. … Overall adverse event profiles appeared to be similar for biologic DMARDs and placebo.

137. Effectiveness and Safety of Bronchial Thermoplasty in Management of Asthma: Evidence Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-202-bronchial-thermoplasty-asthma.pdf
     December 01, 2017 - • BT causes more adverse events (such as worsening of asthma symptoms, respiratory infections, and … • Patients treated with BT developed the following common adverse events: bronchial irritation, chest … Serious adverse events occurred more frequently in BT-treated patients than in patients receiving sham … Serious adverse events attributed to BT were infrequent, and no deaths were reported. … The risk of adverse events is higher early in treatment, while benefit is typically observed weeks to

138. Breast-Biopsy-Update Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy-update_executive.pdf
     September 01, 2014 - • What factors associated with the patient and her breast abnormality influence the adverse events of … Studies included for the assessment of possible adverse events of core needle biopsy (Key Question 2 … Core needle biopsy was only infrequently associated with serious adverse events. … adverse events) compared to core needle biopsy. … Our assessment of the strength of evidence for adverse events is summarized in Table H.

139. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/weight-loss-surgery_research-protocol.pdf
     December 14, 2010 - (i.e. staple-line disruption or ulcer), nutritional deficiencies - LAGB-specific adverse events: … • Adverse events: o Short-term: - mortality - systemic medical complications (i.e. myocardial … KQ3: What are the potential short term adverse effects and/or complications involved with bariatric … Outcome measures for harms, or adverse events, are the same as in KQ3, and KQ5 below. … adverse events  Adverse reactions to medications Figure 1.

140. S5 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s5.pdf
     October 01, 2007 - to structure both interventional and database-oriented studies, particu- larly those concerned with adverse … and state hospital data—for examining initi- ation, persistence, and adherence, and the benefits and adverse … events.13 The National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance … Real-time vaccine safety surveillance for the early detection of adverse events. … A simulation-based evaluation of methods to estimate the impact of an adverse event on hospital length